FOXO4 and colorectal carcinoma: The ChIP results showed that FOXO4 could bind the motif of APC2 and enhance its expression, which indicated that FOXO4 is a key transcriptional regulation factor of APC2, and FOXO4, improving the APC2/β-catenin axis, would be the mechanism of FOXO4 inhibiting CRC.